# FDA Inspection 1116611 - Siegfried Pharma AG - December 13, 2019

Source: https://www.keypedia.com/records/fda_inspections/siegfried-pharma-ag/45309f46-dfd6-433e-8b01-cf409ede8b87
Source feed: FDA_Inspections

> FDA Inspection 1116611 for Siegfried Pharma AG on December 13, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1116611
- Company Name: Siegfried Pharma AG
- Inspection Date: 2019-12-13
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1040552 - 2017-12-08](https://www.keypedia.com/records/fda_inspections/siegfried-pharma-ag/c8ec514a-9b94-415b-96f3-d523881672a5)
- [FDA Inspection 905896 - 2014-11-06](https://www.keypedia.com/records/fda_inspections/siegfried-pharma-ag/c473390f-51f6-40ab-be84-009e235bd1bb)
- [FDA Inspection 676492 - 2010-07-23](https://www.keypedia.com/records/fda_inspections/siegfried-pharma-ag/5da998fd-3273-4d2d-9b6a-3b1b71b67edf)

Company: https://www.keypedia.com/companies/siegfried-pharma-ag/a8b1112e-23c8-4f17-9eb6-0c147beb232a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c